Imigran

Sumatriptan, the active ingredient in Imigran, is a 5‑HT1B/1D receptor agonist presented as a nasal spray for intranasal use. It provides rapid relief of acute migraine attacks in adult patients by targeting cranial blood vessels and trigeminal nerve pathways.

GNH USA supplies Imigran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing, regulatory compliance and reliable global distribution for healthcare providers. The company adheres to EU GMP standards and provides comprehensive support for product registration and post‑marketing surveillance.

Sumatriptan is a triptan medication used for the acute treatment of migraine and related headache disorders. - Migraine (acute): reduces headache intensity and associated nausea, photophobia, and phonophobia. - Migraine with aura (acute): provides relief of headache and visual aura symptoms. - Cluster headache (acute): alleviates pain during an attack when other treatments are unsuitable.

Common Side Effects: - Taste disturbance: altered or unpleasant taste sensation after nasal administration. - Nasal irritation: mild burning or discomfort in the nasal passages. - Dizziness: transient feeling of light‑headedness. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Chest pain or tightness: possible cardiac ischemic symptoms. - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity when combined with other serotonergic agents.

Before using Imigran, consider the following precautions: - Assess cardiovascular risk: avoid in patients with coronary artery disease, uncontrolled hypertension, or history of stroke. - Avoid concomitant serotonergic drugs: risk of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors. - Use with caution in uncontrolled hypertension: monitor blood pressure closely. - Do not exceed recommended number of doses per 24 hours: follow prescriber instructions. - Pregnancy and lactation: safety not established; consult a physician before use. - Store at room temperature: keep in original container, protect from moisture and light.

Sumatriptan may interact with several drug classes. Major Interactions (Avoid): - MAO inhibitors: increase risk of serotonin syndrome. - SSRIs/SNRIs: combined use can precipitate serotonin syndrome. - Ergot alkaloids: concurrent use is contraindicated due to additive vasoconstriction. Moderate Interactions (Monitor Closely): - Beta‑blockers: may raise plasma sumatriptan levels. - CYP3A4 inhibitors (e.g., ketoconazole): can increase exposure. - Antihypertensives: additive blood‑pressure‑lowering effect may occur.